Hi-Tech Pharmacal has received US Food and Drug Administration's (FDA) final approval for its sterile lidocaine HCl jelly, 2%.
Subscribe to our email newsletter
The company claims the jelly is a generic version of APP Pharmaceuticals’ Xylocaine.
Lidocaine HCl jelly, 2% is indicated for the prevention and control of pain in procedures involving the male and female urethra, for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation.
Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing generic and branded prescription and OTC products.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.